Tyrphostin/NN
AG-490/NN
inhibits/VBZ
cytokine-mediated/JJ
JAK3/STAT5a/b/NN
signal/NN
transduction/NN
and/CC
cellular/JJ
proliferation/NN
of/IN
antigen-activated/JJ
human/JJ
T/NN
cells/NNS
./.

Janus/NN
kinase/NN
3/CD
(/(
JAK3/NN
)/)
is/VBZ
a/DT
cytoplasmic/JJ
tyrosine/NN
kinase/NN
required/VBN
for/IN
T/NN
cell/NN
development/NN
and/CC
activated/VBN
by/IN
cytokines/NNS
that/WDT
utilize/VBP
the/DT
interleukin-2/NN
(/(
IL-2/NN
)/)
receptor/NN
common/JJ
gamma/NN
chain/NN
(/(
gamma(c)/NN
)/)
./.
=====
Genetic/JJ
inactivation/NN
of/IN
JAK3/NN
is/VBZ
manifested/VBN
as/IN
severe/JJ
combined/JJ
immunodeficiency/NN
disease/NN
(/(
SCID/NN
)/)
in/IN
humans/NNS
and/CC
mice/NNS
./.
=====
These/DT
findings/NNS
have/VBP
suggested/VBN
that/IN
JAK3/NN
represents/VBZ
a/DT
pharmacological/JJ
target/NN
to/TO
control/VB
certain/JJ
lymphoid-derived/JJ
diseases/NNS
./.
=====
Here/RB
we/PRP
provide/VBP
novel/JJ
evidence/NN
that/IN
AG-490/NN
potently/RB
inhibits/VBZ
the/DT
autokinase/NN
activity/NN
of/IN
JAK3/NN
and/CC
tyrosine/NN
phosphorylation/NN
and/CC
DNA/NN
binding/NN
of/IN
signal/NN
transducer/NN
and/CC
activator/NN
of/IN
transcription/NN
5a/NN
and/CC
5b/NN
(/(
STAT5a/b/NN
)/)
./.
=====
Similar/JJ
inhibitory/JJ
effects/NNS
were/VBD
observed/VBN
with/IN
other/JJ
cytokines/NNS
that/WDT
use/VBP
gamma(c)/NN
./.
=====
AG-490/NN
also/RB
inhibited/VBD
IL-2-mediated/JJ
proliferative/JJ
growth/NN
in/IN
human/JJ
T/NN
cells/NNS
with/IN
an/DT
IC50)/NN
=/JJ
25/CD
microM/NN
that/WDT
was/VBD
partially/RB
recoverable/JJ
./.
=====
Moreover/RB
,/,
we/PRP
demonstrate/VBP
that/IN
this/DT
inhibitor/NN
prevented/VBD
tetanus/NN
toxoid/NN
antigen-specific/JJ
T/NN
cell/NN
proliferation/NN
and/CC
expansion/NN
but/CC
failed/VBD
to/TO
block/VB
activation/NN
of/IN
Zap70/NN
or/CC
p56Lck/NN
after/IN
anti-CD3/JJ
stimulation/NN
of/IN
human/JJ
T/NN
cells/NNS
./.
=====
Taken/VBN
together/RB
,/,
these/DT
findings/NNS
suggest/VBP
that/IN
AG-490/NN
inhibits/VBZ
the/DT
JAK3-mediated/JJ
Type/NN
II/CD
signaling/NN
pathway/NN
but/CC
not/RB
the/DT
T/NN
cell/NN
receptor-derived/JJ
Type/NN
I/CD
pathway/NN
and/CC
possesses/VBZ
therapeutic/JJ
potential/NN
for/IN
T/NN
cell-derived/JJ
pathologies/NNS
such/JJ
as/IN
graft-versus-host/JJ
disease/NN
,/,
allergy/NN
,/,
and/CC
autoimmune/JJ
disorders/NNS
./.